Drug Discovery 2022
ELRIG’s annual Drug Discovery meeting is Europe’s largest meeting for life science professionals. ELRIG hopes to drive scientific progress post-COVID during this renaissance in life sciences.
Will you be there too?
Head to our exhibition stand – #B23
We look forward to meeting you at our exhibition stand, or posters, to discuss how our portfolio of Organ-on-a-chip products and services can help you to optimise the accuracy and efficiency of your drug discovery worklows.
Poster 138: A multi-organ MPS, linking the gut and liver for ADME studies. Dr Yassen Abass
Poster 142: Evaluation of in vitro human alveolar and bronchial microphysiological systems to predict the permeability and absorption of inhaled pulmonary medications. DrEmily Richardson
Poster 171: Evaluating different modalities of drug-induced liver injury using a sensitive and selective human liver microphysiological system and clinical biomarkers. Dr Ovidiu Novac
This conference is free to attend so is a great opportunity for those based in the UK to come and meet the team in person.
Our Team at ELRIG
A seasoned business developer with extensive commercial experience in the life science sector, Adrian Rea joined CN-Bio Innovations as the European Director of Sales in June 2022. He brings valuable experience in the 3D cell culture market from his most recent role at InSphero, where he was responsible for developing business opportunities in European and Asian markets. He was previously Sales Director at Enzo Life Sciences, where he managed the restructuring of the global distributor sales channels and expanding the European sales operations. Adrian graduated from the University of Glasgow and received his PhD in pharmacology from Glasgow Caledonian University.
Dr Atefeh Mobasseri, Field Application Scientist at CN Bio, has an extensive background in tissue engineering and regenerative medicine. Before joining CN Bio, she gained a PhD in Biomedical materials from the University of Manchester and carried out postdoctoral roles at the University of Manchester and Kings College London investigating the interaction, and effect, of 3D scaffolds on cellular behaviour. Since joining CN Bio, she has been supporting their European customers in using CN Bio’s range of PhysioMimixTM systems to generate high content, human-relevant, data.